drugset / Trial / NCT02170636
Bioavailability of BIBR 953 ZW After Oral Administration of BIBR 1048 MS in Healthy Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
Study to assess the amount of BIBR 953 ZW in urine after administration of 50 mg BIBR 1048 bid over three days each administered as four experimental formulations relative to drinking solution with and without coadministration of 40 mg Pantoprazole
Timeline
- Start
- 2002-01
- Primary completion
- 2002-03
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dabigatran etexilate | Unknown | 50 mg | Oral |
| Subject | Pantoprazole | Other / unclassified | 40 mg | — |
Indications
No indication recorded.